Emergent CEO Bob Kramer told CNBC that the company has infrastructure in place to produce Johnson & Johnson and AstraZeneca vaccines around the clock.
source https://www.cnbc.com/2021/03/03/emergent-biosolutions-can-make-1-billion-covid-vaccine-doses-annually.html
0 Comments